Related references
Note: Only part of the references are listed.Sotatercept in patients with osteolytic lesions of multiple myeloma
Kudrat M. Abdulkadyrov et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
The role of bone morphogenetic proteins in myeloma cell survival
Toril Holien et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma
R. Silbermann et al.
LEUKEMIA (2014)
Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
Rajasekhar N. V. S. Suragani et al.
NATURE MEDICINE (2014)
Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
O. E. Olsen et al.
BLOOD CANCER JOURNAL (2014)
Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells
Carlis A. Rejon et al.
CELLULAR SIGNALLING (2013)
Activin, neutrophils, and inflammation: just coincidence?
Paschalis Sideras et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
E. Terpos et al.
ANNALS OF ONCOLOGY (2012)
New insights into the mechanisms of activin action and inhibition
Kelly L. Walton et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC
T. Holien et al.
LEUKEMIA (2012)
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
Sonia Vallet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells
Karen Lavery et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization
Marco Eijken et al.
FASEB JOURNAL (2007)
Bone morphogenetic protein-5,-6 and-7 inhibit growth and induce apoptosis in human myeloma cells
TB Ro et al.
ONCOGENE (2004)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells
Ö Hjertner et al.
BLOOD (2001)
Share Paper
